Literature DB >> 31297878

YAP1 regulates PPARG and RXR alpha expression to affect the proliferation and differentiation of ovine preadipocyte.

Kaiping Deng1, Caifang Ren1, Yixuan Fan1, Jing Pang1, Guomin Zhang1, Yanli Zhang1, Peihua You2, Feng Wang3.   

Abstract

Adipose tissue development is regulated by a serial of developmental signaling pathways. The Hippo pathway is a novel signaling cascade closely associated with adipogenesis. While most of Hippo pathway components had been verified that have a vital role in preadipocytes proliferation and differentiation, little is known about the function of Yes-associated protein 1 (YAP1) in mammalian adipose tissue development. Therefore, we investigated the role of YAP1 in ovine adipose tissue development by in vitro and in vivo experiments. We observed that the adipocyte size in subcutaneous adipose tissue increased with development. YAP1 expression increased during adipose tissue development, while decreased during the differentiation of ovine preadipocytes in vitro. YAP1 knockdown notably promoted lipid accumulation and suppressed ovine preadipocyte proliferation. In addition, we observed that YAP1 deficiency significantly upregulated peroxisome proliferator-activated receptor gamma (PPARG) and retinoid X receptor alpha (RXR alpha) expression. By contrast, overexpression of YAP1 led to the suppression of preadipocyte differentiation, lipid droplets formation, and PPARG expression. In brief, our findings demonstrated that YAP1 regulates the proliferation and differentiation of ovine preadipocyte via altering PPARG and RXR alpha expression.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Hippo pathway; YAP1; adipogenesis; adipose tissue development

Year:  2019        PMID: 31297878     DOI: 10.1002/jcb.29265

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma.

Authors:  Ruth Berthold; Ilka Isfort; Cihan Erkut; Lorena Heinst; Inga Grünewald; Eva Wardelmann; Thomas Kindler; Pierre Åman; Thomas G P Grünewald; Florencia Cidre-Aranaz; Marcel Trautmann; Stefan Fröhling; Claudia Scholl; Wolfgang Hartmann
Journal:  Oncogenesis       Date:  2022-04-22       Impact factor: 6.524

2.  Downregulation of lncRNA Miat contributes to the protective effect of electroacupuncture against myocardial fibrosis.

Authors:  Wenchuan Qi; Xiang Li; Yanrong Ren; Xueying Liu; Hongjuan Fu; Xiao Wang; Xiao Li; Jian Xiong; Qianhua Zheng; Dingjun Cai; Fanrong Liang
Journal:  Chin Med       Date:  2022-05-17       Impact factor: 4.546

3.  miR-27a Regulates Sheep Adipocyte Differentiation by Targeting CPT1B Gene.

Authors:  Bo Li; Xiaoyu Huang; Chen Yang; Ting Ge; Leiyun Zhao; Xiaoqiang Zhang; Lintao Tian; Enping Zhang
Journal:  Animals (Basel)       Date:  2021-12-23       Impact factor: 2.752

4.  Circ003429 Regulates Unsaturated Fatty Acid Synthesis in the Dairy Goat Mammary Gland by Interacting with miR-199a-3p, Targeting the YAP1 Gene.

Authors:  Peixin Jiao; Meimei Zhang; Ziwei Wang; Gege Liang; Xiaolai Xie; Yonggen Zhang; Zhi Chen; Qianming Jiang; Juan J Loor
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

5.  Transcriptome and iTRAQ-Based Proteome Reveal the Molecular Mechanism of Intestinal Injury Induced by Weaning Ewe's Milk in Lambs.

Authors:  Lulu Han; Hui Tao; Lingyun Kang; Shuo Wang; Qiyu Diao; Deping Han; Kai Cui
Journal:  Front Vet Sci       Date:  2022-04-25

6.  Comparative analysis of differentially abundant proteins between high and low intramuscular fat content groups in donkeys.

Authors:  Xiaofan Tan; Yu He; Yanchun Qin; Zhiwei Yan; Jing Chen; Ruixue Zhao; Shenglan Zhou; David M Irwin; Bojiang Li; Shuyi Zhang
Journal:  Front Vet Sci       Date:  2022-07-27

7.  Calcipotriol Inhibits NLRP3 Signal Through YAP1 Activation to Alleviate Cholestatic Liver Injury and Fibrosis.

Authors:  Xiaopeng Wang; Guiyang Wang; Junwen Qu; Zhiqing Yuan; Ruogu Pan; Kewei Li
Journal:  Front Pharmacol       Date:  2020-03-31       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.